Quality of life in climacteric women

References

• Hill K. The demography of menopause. Maturitas 1996;23:113–27
   PubMed Web of Science ®Google Scholar
• World Health Organization. Preamble to the Constitution of the World Health Organization. International Health Conference, New York, June 19–July 22, 1946: Report of the US Delegation, Including the Final Act and Related Documents, Department of State publication 2703, Conference Series 91. New York: WHO, 1946
   Google Scholar
• Schneider HPG, MacLennan AH, Feeny D. Assessment of health-related quality of life in menopause and aging. Climacteric 2008;11:93–107
   PubMed Web of Science ®Google Scholar
• Spilker B, Revicki DA. Taxonomy of quality of life. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia (PA): Lippincott-Raven; 1996:25–31
   Google Scholar
• Hällström T, Samuelsson S. Mental health in the climacteric. The longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand Suppl 1985;130:13–18
   PubMedGoogle Scholar
• Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331–43
   PubMed Web of Science ®Google Scholar
• Juang KD, Wang SJ, Lu SR, Lee S-J, Fuh J-L. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005;52:119–26
   PubMed Web of Science ®Google Scholar
• Clayton AH, Ninan PT. Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women. Prim Care Companion J Clin Psychiatry 2010;12:PCC.08r00747
   PubMedGoogle Scholar
• Ayers B, Hunter MS. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013;16:235–9
   PubMed Web of Science ®Google Scholar
• Williams RE, Levine KB, Kalilani L, et al. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas 2009;62:153–9
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Dennerstein L, Taffe JR, et al. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric 2004;7:375–89
   PubMed Web of Science ®Google Scholar
• Avis NE, Colvin A, Bromberge JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women’s Health Across the Nation (SWAN). Menopause 2009;16:860–9
   PubMed Web of Science ®Google Scholar
• Chedraui P, San Miguel G, Avila C. Quality of life impairment during the female menopausal transition is related to personal and partner factors. Gynecol Endocrinol 2009;25:130–5
   PubMed Web of Science ®Google Scholar
• Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: a population study. Maturitas 2000;34:17–23
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Abraham L, Bushmakin AG, et al. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause 2016;23:1060–6
   PubMed Web of Science ®Google Scholar
• Lock M. Ambiguities of aging: Japanese experience and perceptions of menopause. Cult Med Psychiatry 1986;10:23–46
   PubMed Web of Science ®Google Scholar
• Moilanen JM, Aalto AM, Raitanen J, et al. Physical activity and change in quality of life during menopause – an 8-year follow-up study. Health Qual Life Outcomes 2012;10:8
   PubMed Web of Science ®Google Scholar
• Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29:139–46
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Lehert P, Guthrie JR, Burger HG. Modeling women's health during the menopausal transition: a longitudinal analysis. Menopause 2007;14:53–62
   PubMed Web of Science ®Google Scholar
• Bailey TG, Cable NT, Aziz N, et al. Exercise training reduces the frequency of menopausal hot flushes by improving thermoregulatory control. Menopause 2016;23:708–18
   PubMed Web of Science ®Google Scholar
• Thurston RC, Sowers MR, Chang Y, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the Study of women's health across the nation. Am J Epidemiol 2008;167:78–85
   PubMed Web of Science ®Google Scholar
• Anda RF, Waller MN, Wooten KG, Mast EE, Escobedo LG, Sanderson LM. Behavioral risk factor surveillance, 1988. MMWR CDC Surveill Summ 1990;39:1–21
   PubMedGoogle Scholar
• Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688–703
   PubMed Web of Science ®Google Scholar
• Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. J Am Med Assoc 1959;171:1627–37
   PubMed Web of Science ®Google Scholar
• Greene JG. Measuring the symptoms dimension of quality of life: General and menopause-specific scales and their subscale structure. In: Schneider HPG, ed. Hormone Replacement Therapy and Quality of Life. New York: Parthenon Publishing; 2002:35–43
   Google Scholar
• Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res 1976;20:425–30
   PubMed Web of Science ®Google Scholar
• Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31
   PubMed Web of Science ®Google Scholar
• Girod I, de la Loge C, Keininger D, Hunter MS. Development of a revised version of the Women's Health Questionnaire. Climacteric 2006;9:4–12
   PubMed Web of Science ®Google Scholar
• Le Floch JP, Colau JCI, Zartarian M. Validation d’une méthode d’évaluation de la qualilté de vie en ménopause. Refs En Gynécol Obstétr 1994;2:179–88
   Google Scholar
• Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161–75
   PubMed Web of Science ®Google Scholar
• Schneider HPG, Doeren M. Traits for long-term acceptance of hormone replacement therapy – results of a representative German survey. Eur Menopause J 1996;3:94–8
   Google Scholar
• Potthoff P, Heinemann LA, Schneider HP, et al. Menopause-Rating Skala (MRS): methodische standardisierung in der deutschen Bevölkerung. Zentralbl Gynakol 2000;122:280–6
   PubMedGoogle Scholar
• Perz JM. Development of the menopause symptom list: a factor analytic study of menopause associated symptoms. Women Health 1997;25:53–69
   PubMed Web of Science ®Google Scholar
• Jacobs P, Hyland ME, Ley A. Self rated menopausal status and quality of life in women aged 40–63 years. Br J Health Psych 2000;5:395–411
   Web of Science ®Google Scholar
• Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2002;9:402–10
   PubMed Web of Science ®Google Scholar
• Schneider HPG, Heinemann LAJ, Thiele K. The Menopause Rating Scale (MRS): cultural and linguistic validation into English. Life Med Sci Online 2002;3. DOI 101072/LO 0305326
   Google Scholar
• Heinemann LA, Potthoff P, Schneider HPG. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes 2003;1:28
   PubMedGoogle Scholar
• Barnabei VM, Cochrane BB, Aragaki AK, for the Women’s Health Initiative Investigators, et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005;105:1063–73
   PubMed Web of Science ®Google Scholar
• Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209–18
   PubMed Web of Science ®Google Scholar
• Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591–7
   PubMed Web of Science ®Google Scholar
• Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–54
   PubMed Web of Science ®Google Scholar
• Brunner RL, Gass M, Aragaki A, for the Women’s Health Initiative Investigators, et al. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med 2005;165:1976–86
   PubMed Web of Science ®Google Scholar
• Welton AJ, Vickers MR, Kim J, WISDOM team, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008;337:1190–8
   PubMed Web of Science ®Google Scholar
• Eviö S, Pekkarinen T, Sintonen H, Tiitinen A, Välimäki MJ. The effect of hormone therapy on the health-related quality of life in elderly women. Maturitas 2006;56:122–8
   PubMed Web of Science ®Google Scholar
• Zethräus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality of life and willingness to pay. Br J Obstet Gynaecol 1997;104:1191–5
   PubMedGoogle Scholar
• Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993;307:836–40
   PubMed Web of Science ®Google Scholar
• Wiklund I, Karlberg J, Mattson L-A. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824–30
   PubMed Web of Science ®Google Scholar
• Skarsgard C, Berg GE, Ekblad S, Wiklund I, Hammar ML. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints. Maturitas 2000;36:123–30
   PubMed Web of Science ®Google Scholar
• Nielsen TF, Ravn P, Pitkin J, Christiansen C. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study. Maturitas 2006;53:184–90
   PubMed Web of Science ®Google Scholar
• Hess R, Colvin A, Avis NE, et al. The impact of hormone therapy on health-related quality of life: longitudinal results from the Study of Women’s Health Across the Nation. Menopause 2008;15:422–8
   PubMed Web of Science ®Google Scholar
• Hilditch JR, Lewis J, Ross AH, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Maturitas 1996;24:177–84
   PubMed Web of Science ®Google Scholar
• Gambacciani M. New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 2004;24:231–8
   PubMed Web of Science ®Google Scholar
• Caan B, LaCroix AZ, Joffe H, et al. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes. Menopause 2015;22:607–15
   PubMed Web of Science ®Google Scholar
• Yaffe K, Vittinghoff E, Ensrud KE, et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 2006;63:945–50
   PubMed Web of Science ®Google Scholar
• Setty P, Redekal L, Warren MP. Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women’s Health Initiative in New York City. Menopause 2016;23:7–10
   PubMed Web of Science ®Google Scholar
• Limouzin-Lamothe MA, Mairon N, Joyce JRB, Le Gal M. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol 1994;170:618–24
   PubMed Web of Science ®Google Scholar
• NIH State-of-the-Science Conference Statement on management of menopause-related symptoms. NIH Consens State Sci Statements 2005;22:1–38
   Google Scholar
• Salpeter SR, Buckley NS, Liu H, Salpeter EE. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med 2009;122:42–52
   PubMed Web of Science ®Google Scholar
• Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2011;95(Suppl 1):S1–S66
   Web of Science ®Google Scholar
• de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised Global Consensus Statement on Menopausal Hormone Therapy. Climacteric 2016;19:313–15
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. for the IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar